294
Views
24
CrossRef citations to date
0
Altmetric
Letters to the Editor

Low rate of seroconversion after mRNA anti-SARS-CoV-2 vaccination in patients with hematological malignancies

, , ORCID Icon, , , , , & show all
Pages 3308-3310 | Received 20 May 2021, Accepted 10 Jul 2021, Published online: 26 Jul 2021
 

Disclosure statement

No potential conflict of interest was reported by the author(s).

Author contributions

Drs Re, Barrière, Chamorey, and Peyrade had full access to all of the data in the study and take responsibility for the integrity of the data and the accuracy of the data analysis. Concept and design: all authors. Acquisition, analysis, or interpretation of data: all authors. Drafting of the manuscript: Dr Re. Critical revision of the manuscript for important intellectual content: all authors. Statistical analysis: Dr Chamorey. Administrative, technical, or material support: all authors. Supervision: Drs Re and Barrière.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.